ARTICLES
Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants in Children and Adolescents

https://doi.org/10.1097/00004583-199611000-00018Get rights and content

ABSTRACT

Objective

Tricyclic antidepressants (TCAs) play an important role in the treatment of pediatric psychiatric disorders. Despite widespread clinical use, concerns about their possible cardiovascular risk have arisen following several published reports of sudden death associated with their use in children. Accordingly, available evidence concerning TCA-associated cardiovascular effects in children and adolescents was surveyed.

Method

A systematic literature search from 1967 to 1996 identified relevant pediatric studies that evaluated cardiovascular effects of TCAs.

Results

Twenty-four studies involving 730 children and adolescents given imipramine, amitriptyline, desipramine, or nortriptyline were found. TCA treatment was associated with minor increases in systolic and diastolic blood pressure, in heart rate, and in the electrocardiographic (ECG) conduction parameters PR, QRS, and QTc. Holter ECG monitoring and exercise testing also revealed minor treatment effects. Some ECG changes related to specific TCAs emerged. Few age-related ECG differences in TCA-treated children, adolescents, or adults were detected. Associations of ECG abnormalities and relatively higher serum TCA levels were found.

Conclusion

TCA treatment in children and adolescents, like that in adults, is associated with cardiovascular changes of uncertain, but probably minor, clinical significance. More information is needed on the contribution of other physiological conditions on the cardiovascular system during exposure to TCAs. Guidelines for using TCAs in children and adolescents are presented.

REFERENCES (81)

  • B Geller et al.

    Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder

    J Am Acad Child Adolesc Psychiatry

    (1992)
  • BS Jandhyala et al.

    Effects of several tricyclic antidepressants on the hemodynamics and myocardial contractibiliry of the anesthetized dogs

    Eur J Pharmacol

    (1977)
  • HL Leonard et al.

    Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents

    J Am Acad Child Adolesc Psychiatry

    (1995)
  • HL Leonard et al.

    Pharmacotherapy of childhood obsessive-compulsive disorder

    Psychiatr Clin North Am

    (1989)
  • MA Pfeifer et al.

    Differential changes of autonomic nervous system function with age in man

    Am J Med

    (1983)
  • J Puig-Antich et al.

    Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder

    J Am Acad Child Psychiatry

    (1979)
  • M Riddle et al.

    Another sudden death in a child treated with desipramine

    J Am Acad Child Adolesc Psychiatry

    (1993)
  • MA Riddle et al.

    Sudden death in children receiving Norpramin: a review of three reported cases and commentary

    J Am Acad Child Adolesc Psychiatry

    (1991)
  • ND Ryan et al.

    Relative safety of single versus divided dose imipramine in adolescent major depression

    J Am Acad Child Adolesc Psychiatry

    (1987)
  • KR Saraf et al.

    EKG effects of imipramine treatment in children

    J Am Acad Child Psychiatry

    (1978)
  • JS Schroeder et al.

    Cardiovascular effects of desipramine in children

    J Am Acad Child Adolesc Psychiatry

    (1989)
  • T Spencer et al.

    Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

    J Am Acad Child Adolesc Psychiatry

    (1996)
  • BT Walsh et al.

    Effects of desipramine on autonomic control of the heart

    J Am Acad Child Adolesc Psychiatry

    (1994)
  • J Werry

    Cardiac arrhythmias make desipramine an unacceptable choice in children

    J Am Acad Child Adolesc Psychiatry

    (1995)
  • TE Wilens et al.

    Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine

    J Am Acad Child Adolesc Psychiatry

    (1993)
  • TE Wilens et al.

    A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents

    J Am Acad Child Adolesc Psychiatry

    (1993)
  • JC Anderson et al.

    DSM-III disorders in preadolescent children

    Arch Gen Psychiatry

    (1987)
  • RJ Baldessarini

    Chemotherapy in Psychiatry

    (1996)
  • J Biederman et al.

    Estimation of the association between desipramine and the risk for sudden death in 5-to 14-year old children

    J Clin Psychiatry

    (1995)
  • EJ Costello

    Developments in child psychiatry epidemiology

    J Am Acad Child Adolesc Psychiatry

    (1989)
  • RB Dell et al.

    Model for the kinetics of imipramine and its metabolites in adolescents

    Ther Drug Monit

    (1990)
  • DF Dickinson et al.

    Ambulatory electrocardiographic monitoring in 100 healthy teenage boys

    Br Heart J

    (1984)
  • M Donnelly et al.

    Treatment of childhood hyperactivity with desipramine: plasma drug concentration, cardiovascular effects, plasma and urinary catecholamine levels, and clinical response

    Clin Pharmacol Ther

    (1986)
  • M Fava et al.

    Research Designs and Methods in Psychiatry

    (1992)
  • Fletcher SE, Case CL, Williamson CE, Gillette PC, Bucklee DS, Hewett KW (1992), Developmental electrophysiologic...
  • A Garson et al.
  • B Geller et al.

    Serial monitoring and achievement of steady state nortriptyline plasma levels in depressed children and adolescents

    J Clin Psychopharmacol

    (1985)
  • B Geller et al.

    Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a “fixed plasma level” design

    Psychopharmacol Bull

    (1990)
  • B Geller et al.

    Serial ECG measurements at controlled plasma levels of nortriptyline in depressed children

    Am J Psychiatry

    (1985)
  • EV Giardina et al.

    The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations

    Circulation

    (1979)
  • Cited by (0)

    This work was supported in part by NIMH grants MH-01175 (Dr. Wilens), MH-31154 and MH-47370 (Dr. Baldessarini), MH-40273 and MH-40646 (Dr. Geller), and the Anderson, Corneel, Temte, & Whalin Funds (Dr. Baldessarini).

    View full text